Peripartum mood disturbances screening: Difference between revisions
Homa Najafi (talk | contribs) (Created page with "__NOTOC__ {{Peripartum mood disturbances}} {{CMG}}; {{AE}}{{Sunita}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. O...") |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 33: | Line 33: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Primary care]] | |||
[[Category:Obstetrics]] | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Psychiatry]] | |||
Revision as of 15:30, 29 July 2021
|
Peripartum mood disturbances Microchapters |
|
Differentiating Peripartum mood disturbances from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Peripartum mood disturbances screening On the Web |
|
American Roentgen Ray Society Images of Peripartum mood disturbances screening |
|
Risk calculators and risk factors for Peripartum mood disturbances screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunita Kumawat, M.B.B.S[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]